{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:43Z","timestamp":1792788163311,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:00:00Z","timestamp":1783209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the NHC Key Laboratory of Thrombosis and Hemostasis, the First Affiliated Hospital of Soochow University","award":["KJS2420"],"award-info":[{"award-number":["KJS2420"]}],"id":[{"id":"https:\/\/ror.org\/051jg5p78","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Gusu Talent Program","award":["GSWS2023083"],"award-info":[{"award-number":["GSWS2023083"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12201601, U23A20453, 82270223 and 82170209"],"award-info":[{"award-number":["12201601, U23A20453, 82270223 and 82170209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200197"],"award-info":[{"award-number":["82200197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anhui Provincial Department of Education Scientific Research Project","award":["2023AH010079"],"award-info":[{"award-number":["2023AH010079"]}],"id":[{"id":"https:\/\/ror.org\/012m7k033","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Anhui Provincial Natural Science Foundation","award":["2308085J09"],"award-info":[{"award-number":["2308085J09"]}]},{"name":"USTC Research Funds of the Double First-Class Initiative","award":["YD9110002047"],"award-info":[{"award-number":["YD9110002047"]}]},{"name":"International Cooperation Projects in Anhui Province","award":["2023h11020005"],"award-info":[{"award-number":["2023h11020005"]}]},{"name":"PRIN 2022 PNRR","award":["P20225KJ5L"],"award-info":[{"award-number":["P20225KJ5L"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-026-02197-8","type":"journal-article","created":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T12:54:16Z","timestamp":1783256056000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TCA-controlled histone succinylation identifies IDH3B as a prognostic and therapeutic target in AML"],"prefix":"10.1186","volume":"18","author":[{"given":"Minhui","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kepeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiewen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Iuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,5]]},"reference":[{"issue":"10393","key":"2197_CR1","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","volume":"401","author":"CD DiNardo","year":"2023","unstructured":"DiNardo CD, Erba HP, Freeman SD, Wei AH. Acute myeloid leukaemia. Lancet. 2023;401(10393):2073\u201386.","journal-title":"Lancet"},{"issue":"10","key":"2197_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1182\/blood.2022018092","volume":"141","author":"SK Mishra","year":"2023","unstructured":"Mishra SK, Millman SE, Zhang L. Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets. Blood. 2023;141(10):1119\u201335.","journal-title":"Blood"},{"issue":"3","key":"2197_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.stem.2021.02.013","volume":"28","author":"CL Jones","year":"2021","unstructured":"Jones CL, Inguva A, Jordan CT. Targeting energy metabolism in cancer stem cells: progress and challenges in leukemia and solid tumors. Cell Stem Cell. 2021;28(3):378\u201393.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2197_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.molmed.2020.10.001","volume":"27","author":"R Culp-Hill","year":"2021","unstructured":"Culp-Hill R, D\u2019Alessandro A, Pietras EM. Extinguishing the embers: targeting AML metabolism. Trends Mol Med. 2021;27(4):332\u201344.","journal-title":"Trends Mol Med"},{"issue":"5","key":"2197_CR5","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones CL, Stevens BM, D\u2019Alessandro A, Reisz JA, Culp-Hill R, Nemkov T, et al. Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell. 2018;34(5):724-40.e4.","journal-title":"Cancer Cell"},{"key":"2197_CR6","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041544","author":"LV Pinheiro","year":"2025","unstructured":"Pinheiro LV, Costa-Pinheiro P, Wellen KE. Metabolic signaling in cancer. Cold Spring Harb Perspect Med. 2025. https:\/\/doi.org\/10.1101\/cshperspect.a041544.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2197_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semcancer.2017.06.012","volume":"47","author":"R Loureiro","year":"2017","unstructured":"Loureiro R, Mesquita KA, Magalh\u00e3es-Novais S, Oliveira PJ, Vega-Naredo I. Mitochondrial biology in cancer stem cells. Semin Cancer Biol. 2017;47:18\u201328.","journal-title":"Semin Cancer Biol"},{"issue":"24","key":"2197_CR8","doi-asserted-by":"publisher","first-page":"EMBJ2022112348","DOI":"10.15252\/embj.2022112348","volume":"42","author":"YW Zhang","year":"2023","unstructured":"Zhang YW, Sch\u00f6nberger K, Cabezas-Wallscheid N. Bidirectional interplay between metabolism and\u00a0epigenetics in hematopoietic stem cells and\u00a0leukemia. EMBO J. 2023;42(24):EMBJ2022112348.","journal-title":"EMBO J"},{"issue":"1","key":"2197_CR9","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41467-017-01384-9","volume":"8","author":"J Simithy","year":"2017","unstructured":"Simithy J, Sidoli S, Yuan Z-F, Coradin M, Bhanu NV, Marchione DM, et al. Characterization of histone acylations links chromatin modifications with metabolism. Nat Commun. 2017;8(1):1141.","journal-title":"Nat Commun"},{"issue":"1","key":"2197_CR10","first-page":"144","volume":"41","author":"Y Fu","year":"2022","unstructured":"Fu Y, Yu J, Li F, Ge S. Oncometabolites drive tumorigenesis by enhancing protein acylation: from chromosomal remodelling to nonhistone modification. J Exper Clin Cancer Res CR. 2022;41(1):144.","journal-title":"J Exper Clin Cancer Res CR"},{"key":"2197_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116147","author":"M Gao","year":"2025","unstructured":"Gao M, Shi M, Ding H, Xu L, Zhao N, Wang L, et al. SUCLG1 deficiency-induced histone succinylation impairs oncogene expression in acute myeloid leukemia. Cell Rep. 2025. https:\/\/doi.org\/10.1016\/j.celrep.2025.116147.","journal-title":"Cell Rep"},{"issue":"12","key":"2197_CR12","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1038\/s44318-024-00101-9","volume":"43","author":"W Yan","year":"2024","unstructured":"Yan W, Xie C, Sun S, Zheng Q, Wang J, Wang Z, et al. SUCLG1 restricts POLRMT succinylation to enhance mitochondrial biogenesis and leukemia progression. EMBO J. 2024;43(12):2337\u201367.","journal-title":"EMBO J"},{"issue":"7","key":"2197_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nsmb.3249","volume":"23","author":"O Gilan","year":"2016","unstructured":"Gilan O, Lam EY, Becher I, Lugo D, Cannizzaro E, Joberty G, et al. Functional interdependence of BRD4 and DOT1L in MLL leukemia. Nat Struct Mol Biol. 2016;23(7):673\u201381.","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"2197_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cell.2005.09.025","volume":"123","author":"A Yokoyama","year":"2005","unstructured":"Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M, Cleary ML. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell. 2005;123(2):207\u201318.","journal-title":"Cell"},{"issue":"7954","key":"2197_CR15","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","volume":"615","author":"GC Issa","year":"2023","unstructured":"Issa GC, Aldoss I, DiPersio J, Cuglievan B, Stone R, Arellano M, et al. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature. 2023;615(7954):920\u20134.","journal-title":"Nature"},{"issue":"1","key":"2197_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1200\/JCO.24.00826","volume":"43","author":"GC Issa","year":"2025","unstructured":"Issa GC, Aldoss I, Thirman MJ, DiPersio J, Arellano M, Blachly JS, et al. Menin inhibition with revumenib for KMT2A-rearranged relapsed or refractory acute leukemia (AUGMENT-101). J Clin Oncol: Off J Am Soc Clin Oncol. 2025;43(1):75\u201384.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"issue":"6","key":"2197_CR17","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen P, Hovestadt V, Wadsworth Ii MH, Hughes TK, Griffin GK, Battaglia S, et al. Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity. Cell. 2019;176(6):1265-81.e24.","journal-title":"Cell"},{"issue":"5","key":"2197_CR18","first-page":"589","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics (Oxford, England). 2010;26(5):589\u201395.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"9","key":"2197_CR19","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9(9):R137.","journal-title":"Genome Biol"},{"key":"2197_CR20","doi-asserted-by":"publisher","first-page":"1144430","DOI":"10.3389\/fonc.2023.1144430","volume":"13","author":"C Meng","year":"2023","unstructured":"Meng C, Sun Y, Liu G. Establishment of a prognostic model for ovarian cancer based on mitochondrial metabolism-related genes. Front Oncol. 2023;13:1144430.","journal-title":"Front Oncol"},{"issue":"5","key":"2197_CR21","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/j.1365-2141.2008.07261.x","volume":"142","author":"A Kohlmann","year":"2008","unstructured":"Kohlmann A, Kipps TJ, Rassenti LZ, Downing JR, Shurtleff SA, Mills KI, et al. An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase. Br J Haematol. 2008;142(5):802\u20137.","journal-title":"Br J Haematol"},{"issue":"15","key":"2197_CR22","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1200\/JCO.2009.23.4732","volume":"28","author":"T Haferlach","year":"2010","unstructured":"Haferlach T, Kohlmann A, Wieczorek L, Basso G, Kronnie GT, B\u00e9n\u00e9 MC, et al. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol: Off J Am Soc Clin Oncol. 2010;28(15):2529\u201337.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"issue":"7728","key":"2197_CR23","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","volume":"562","author":"JW Tyner","year":"2018","unstructured":"Tyner JW, Tognon CE, Bottomly D, Wilmot B, Kurtz SE, Savage SL, et al. Functional genomic landscape of acute myeloid leukaemia. Nature. 2018;562(7728):526\u201331.","journal-title":"Nature"},{"issue":"4","key":"2197_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424\u201347.","journal-title":"Blood"},{"issue":"12","key":"2197_CR25","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1182\/blood-2016-10-696054","volume":"129","author":"D Thomas","year":"2017","unstructured":"Thomas D, Majeti R. Biology and relevance of human acute myeloid leukemia stem cells. Blood. 2017;129(12):1577\u201385.","journal-title":"Blood"},{"key":"2197_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100850","volume":"50","author":"E O\u2019Reilly","year":"2021","unstructured":"O\u2019Reilly E, Zeinabad HA, Szegezdi E. Hematopoietic versus leukemic stem cell quiescence: challenges and therapeutic opportunities. Blood Rev. 2021;50:100850.","journal-title":"Blood Rev"},{"issue":"3","key":"2197_CR27","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41375-019-0604-8","volume":"34","author":"AH Elsayed","year":"2020","unstructured":"Elsayed AH, Rafiee R, Cao X, Raimondi S, Downing JR, Ribeiro R, et al. A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia. Leukemia. 2020;34(3):735\u201345.","journal-title":"Leukemia"},{"issue":"7633","key":"2197_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","volume":"540","author":"SW Ng","year":"2016","unstructured":"Ng SW, Mitchell A, Kennedy JA, Chen WC, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540(7633):433\u20137.","journal-title":"Nature"},{"issue":"5930","key":"2197_CR29","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1126\/science.1164097","volume":"324","author":"KE Wellen","year":"2009","unstructured":"Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 2009;324(5930):1076\u201380.","journal-title":"Science"},{"key":"2197_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.01.005","author":"S Trefely","year":"2020","unstructured":"Trefely S, Lovell CD, Snyder NW, Wellen KE. Compartmentalised acyl-CoA metabolism and roles in chromatin regulation. Mol Metab. 2020. https:\/\/doi.org\/10.1016\/j.molmet.2020.01.005.","journal-title":"Mol Metab"},{"issue":"1","key":"2197_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23(1):27\u201347.","journal-title":"Cell Metab"},{"issue":"1","key":"2197_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11(1):102.","journal-title":"Nat Commun"},{"issue":"2","key":"2197_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF00926514","volume":"135","author":"MM Sola","year":"1994","unstructured":"Sola MM, Oliver FJ, Salto R, Guti\u00e9rrez M, Vargas A. Citrate inhibition of rat-kidney cortex phosphofructokinase. Mol Cell Biochem. 1994;135(2):123\u20138.","journal-title":"Mol Cell Biochem"},{"key":"2197_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00826-6","author":"W Fiskus","year":"2023","unstructured":"Fiskus W, Mill CP, Birdwell C, Davis JA, Das K, Boettcher S, et al. Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1. Blood Cancer J. 2023. https:\/\/doi.org\/10.1038\/s41408-023-00826-6.","journal-title":"Blood Cancer J"},{"issue":"1","key":"2197_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","volume":"20","author":"KM Bernt","year":"2011","unstructured":"Bernt KM, Zhu N, Sinha AU, Vempati S, Faber J, Krivtsov AV, et al. MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell. 2011;20(1):66\u201378.","journal-title":"Cancer Cell"},{"issue":"1","key":"2197_CR36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41421-020-00220-7","volume":"6","author":"P Sun","year":"2020","unstructured":"Sun P, Liu Y, Ma T, Ding J. Structure and allosteric regulation of human NAD-dependent isocitrate dehydrogenase. Cell Discovery. 2020;6(1):94.","journal-title":"Cell Discovery"},{"issue":"2","key":"2197_CR37","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ccell.2018.04.011","volume":"34","author":"MS Waitkus","year":"2018","unstructured":"Waitkus MS, Diplas BH, Yan H. Biological role and therapeutic potential of IDH mutations in cancer. Cancer Cell. 2018;34(2):186\u201395.","journal-title":"Cancer Cell"},{"issue":"7","key":"2197_CR38","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.stem.2025.04.012","volume":"32","author":"M Sirenko","year":"2025","unstructured":"Sirenko M, Lee S, Sun Z, Chaligne R, Loghavi S, Asimomitis G, et al. Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia. Cell Stem Cell. 2025;32(7):1102-21.e5.","journal-title":"Cell Stem Cell"},{"issue":"10","key":"2197_CR39","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/ng.223","volume":"40","author":"DT Hartong","year":"2008","unstructured":"Hartong DT, Dange M, McGee TL, Berson EL, Dryja TP, Colman RF. Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle. Nat Genet. 2008;40(10):1230\u20134.","journal-title":"Nat Genet"},{"issue":"22","key":"2197_CR40","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1182\/blood-2015-05-646240","volume":"126","author":"M Garg","year":"2015","unstructured":"Garg M, Nagata Y, Kanojia D, Mayakonda A, Yoshida K, Haridas Keloth S, et al. Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse. Blood. 2015;126(22):2491\u2013501.","journal-title":"Blood"},{"issue":"13","key":"2197_CR41","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1158\/0008-5472.CAN-18-2341","volume":"79","author":"Q Wu","year":"2019","unstructured":"Wu Q, Zhang W, Xue L, Wang Y, Fu M, Ma L, et al. APC\/C-CDH1-Regulated IDH3\u03b2 Coordinates with the Cell Cycle to Promote Cell Proliferation. Can Res. 2019;79(13):3281\u201393.","journal-title":"Can Res"},{"issue":"1","key":"2197_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13046-022-02252-1","volume":"41","author":"Y Chen","year":"2022","unstructured":"Chen Y, Liu L, Xia L, Wu N, Wang Y, Li H, et al. TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1\u03b1 degradation. J Exper Clin Cancer Res: CR. 2022;41(1):44.","journal-title":"J Exper Clin Cancer Res: CR"},{"issue":"14","key":"2197_CR43","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1158\/1078-0432.CCR-23-3806","volume":"30","author":"X Peng","year":"2024","unstructured":"Peng X, Zhao H, Ye L, Hou F, Yi Z, Ren Y, et al. Biomarker identification and risk prediction model development for differentiated thyroid carcinoma lung metastasis based on primary lesion proteomics. Clin Cancer Res. 2024;30(14):3059\u201372.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2197_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102387","volume":"298","author":"S Zhu","year":"2022","unstructured":"Zhu S, Huang J, Xu R, Wang Y, Wan Y, McNeel R, et al. Isocitrate dehydrogenase 3b is required for spermiogenesis but dispensable for retinal viability. J Biol Chem. 2022;298(9):102387.","journal-title":"J Biol Chem"},{"issue":"1","key":"2197_CR45","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","volume":"149","author":"P Filippakopoulos","year":"2012","unstructured":"Filippakopoulos P, Picaud S, Mangos M, Keates T, Lambert JP, Barsyte-Lovejoy D, et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell. 2012;149(1):214\u201331.","journal-title":"Cell"},{"issue":"1","key":"2197_CR46","doi-asserted-by":"publisher","first-page":"13855","DOI":"10.1038\/ncomms13855","volume":"7","author":"TCR Miller","year":"2016","unstructured":"Miller TCR, Simon B, Rybin V, Gr\u00f6tsch H, Curtet S, Khochbin S, et al. A bromodomain\u2013DNA interaction facilitates acetylation-dependent bivalent nucleosome recognition by the BET protein BRDT. Nat Commun. 2016;7(1):13855.","journal-title":"Nat Commun"},{"issue":"6","key":"2197_CR47","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.molcel.2015.04.011","volume":"58","author":"JS Roe","year":"2015","unstructured":"Roe JS, Mercan F, Rivera K, Pappin DJ, Vakoc CR. BET Bromodomain inhibition suppresses the function of hematopoietic transcription factors in acute myeloid Leukemia. Mol Cell. 2015;58(6):1028\u201339.","journal-title":"Mol Cell"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02197-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02197-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02197-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:53:45Z","timestamp":1790549625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-026-02197-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,5]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2197"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02197-8","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,5]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal and human study protocols were approved by the Ethics Committee of the First Affiliated Hospital of USTC, with approval numbers 2023-N(A)-55 and 2024KY-184. Written informed consent was obtained from all human participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"174"}}